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Growth predictors and prognosis of small abdominal aortic aneurysms
Felix J.V. Schlo¨sser, Marco J.D. Tangelder, Hence J.M. Verhagen, Geert
J.M.G. van der Heijden, Bart E. Muhs, Yolanda van der Graaf and Frans L.
Moll
Objective. Evidence regarding the influence of cardiovascular risk factors, co-
morbidities, and patient characteristics on the growth of small abdominal
aortic aneurysms (AAA) is limited. We assessed, in an observational cohort
study, rupture rates, risks of mortality, and the effects of cardiovascular
risk factors and patient demographics on growth rates of small AAAs.
Methods. Between September 1996 and January 2005, 5057 patients with
manifest arterial vascular disease or cardiovascular risk factors were included
in the Second Manifestation of ARTerial disease (SMART) study. Measure-
ments of the abdominal aortic diameter were performed in all patients. All
patients with an initial AAA diameter between 30 and 55 mm were selected
for this study. All AAA measurements during follow-up until August 2007
were collected. Multivariate regression analysis was performed to calculate
the effects of demographic patient characteristics, initial AAA diameter,
and cardiovascular risk factors on AAA growth.
Results. Included were 230 patients, with a mean age of 66 years and 90%
were male. Seven AAA ruptures (six fatal) occurred in 755 patient years of
follow-up (rupture rate 0.9% per patient-year). In 147 patients, AAA mea-
surements were performed for a period of more than 6 months. The median
follow-up time was 3.3 years (mean 4.0, range 0.5 to 11.1 years, standard de-
viation (SD) 2.5). Mean AAA diameter was 38.8 mm (SD 6.8) and mean ex-
pansion rate 2.5 mm/y. Patients using lipid-lowering drugs had a 1.2 mm/y
(95% confidence interval [CI] 2.34 to 0.060 mm/y) lower AAA growth
rate compared to nonusers of these drugs. Initial AAA diameter was associ-
ated with a 0.09 mm/y (95% CI 0.01 to 0.18 mm/y) higher growth rate per
millimetre increase of the diameter. No other factors, including blood lipid
values, were independently associated with AAA growth.
Conclusions. Lipid-lowering drug treatment and initial AAA diameter ap-
pear to be independently associated with lower AAA growth rates. The
risk of rupture of these small abdominal aortic aneurysms was low, which
pleads for watchful waiting.
Renal perfusion with venous blood extends the permissible suprarenal
clamp time in abdominal aortic surgery
Maximilian Pichlmaier, Ludwig Hoy, Mathias Wilhelmi, Nawid Khaladj, Axel
Haverich and Omke E. Teebken
Objective. Suprarenal clamping in abdominal aortic surgery is associated
with a significant risk of postoperative renal failure, general morbidity, and
mortality. Arterial access for temporary shunting in these patients is difficult,
and arterial perfusion techniques are typically complex. This study evaluated
if renal perfusion with venous blood using a minimal pump setup and
intermediate-level heparinization prevents a decline in postoperative renal
function in patients requiring suprarenal clamping for aortic reconstructive
surgery.
Methods. Renal perfusion was achieved using a roller pump supplied
with venous blood from a central venous catheter under medium-level hep-
arinization to feed two perfusion balloon catheters. The calculated glomeru-
lar filtration rate was observed for 10 postoperative days and compared with
the rate in patients with suprarenal clamping without renal perfusion.
Results. From 2001 to 2007, 158 patients underwent surgical reconstruc-
tion involving the pararenal aorta through a midline abdominal incision. Re-
nal perfusion was started in 2006 and was always attempted if suprarenal
clamping was anticipated preoperatively. Twenty-six patients received renal
perfusion, and 132 also requiring suprarenal clamping did not. Of the latter,
109 were included in the control group. Five patients died 30 days (3.7%),
one in the perfusion group. On average, there was a postoperative loss of
renal performance in both groups. Dialysis was required postoperatively in
13 patients without renal perfusion, 4 of them long term (3.7%), but not in pa-
tients with renal perfusion. The reduction in glomerular filtration rate at 10
days in the nonperfused group was significantly higher than in the perfused
group (7.24 vs 0.89 mL/min) despite a significantly longer suprarenal clamp
time in the latter (25.5 vs 45.5 minutes). Multivariate analysis showed a signif-
icant reduction in the loss of glomerular filtration rate with perfusion
(P = .007) if clamp time and preoperative renal function were taken into
account. Patients with preoperative renal impairment showed the greatest
benefit from the perfusion.
Conclusions. The setup for renal perfusion with venous blood during su-
prarenal clamping was simple and safe. Perfusion significantly reduced the
reduction of renal function in the immediate postoperative period, suggest-
ing that clamp time may thus be safely be extended to allow for complex re-
construction of the pararenal aortic segment. The benefit was most marked
for patients with preoperative renal impairment.
Comparison of the effects of open and endovascular aortic aneurysm
repair on long-term renal function using chronic kidney disease
staging based on glomerular filtration rate
Joseph L. Mills Sr., Son T. Duong, Luis R. Leon Jr., Kaoru R. Goshima, Daniel
M. Ihnat, Christopher S. Wendel and Angelika Gruessner
Objective. It has been suggested that endovascular aneurysm repair (EVAR)
in concert with serial contrast-enhanced computed tomography (CT) surveil-
lance adversely impacts renal function. Our primary objectives were to assess
serial renal function in patients undergoing EVAR and open repair (OR) and
to evaluate the relative effects of method of repair on renal function.
Methods. A thorough retrospective chart reviewwas performed on 223 consec-
utive patients (103 EVAR, 120OR)who underwent abdominal aortic aneurysm
(AAA) repair. Demographics, pertinent risk factors, CT scan number, morbid-
ity, and mortality were recorded in a database. Baseline, 30- and 90-day, and
most recent glomerular filtration rate (GFR) were calculated. Mean GFR
changes and renal function decline (using Chronic KidneyDisease [CKD] stag-
ing and Kaplan-Meier plot) were determined. EVAR and OR patients were
compared.CKDprevalence (stage 3,NationalKidney Foundation)wasdeter-
mined before repair and in longitudinal follow-up. Observed-expected (OE)
ratios for CKD were calculated for EVAR and OR patients by comparing ob-
served CKD prevalence with the expected, age-adjusted prevalence.
Results. The only baseline difference between EVAR and OR cohorts was
female gender (4% vs 12%, P ¼ .029). Thirty-day GFR was significantly re-
duced in OR patients (P ¼ .047), but it recovered and there were no differences
in mean GFR at a mean follow-up of 23.2 months. However, 18% to 39% of pa-
tients in the EVAR andOR groups developed significant renal function decline
over time depending on its definition. OE ratios for CKD prevalence were
greater in AAApatients at baseline (OE 1.28-3.23, depending upon age group).
During follow-up, the prevalence and severity of CKD increased regardless of
method of repair (OE 1.8-9.0). Deterioration of renal function was indepen-
dently associated with age>70 years in all patients (RR 2.92) and performance
of EVAR compared with OR (RR 3.5) during long-term follow-up.
Conclusions. Compared with EVAR, OR was associated with a significant but
transient fall in GFR at 30 days. Renal function decline after AAA repair was
common, regardless of method, especially in patients >70 years of age. How-
ever, the renal function decline was significantly greater by Kaplan-Meier
analysis in EVAR than OR patients during long-term follow-up. More aggres-
sive strategies to monitor and preserve renal function after AAA repair are
warranted.
What is the clinical utility of a 6-month computed tomography in the
follow-up of endovascular aneurysm repair patients?
Michael R. Go, Joel E. Barbato, Robert Y. Rhee and Michel S. Makaroun
Objective. A drawback of endovascular aneurysm repair (EVAR) is the need
for ongoing surveillance. Follow-up schedules including 1-, 6-, and 12-month* Full articles available online at www.jvascsurg.org
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computed tomography (CT) established by regulatory trials have been car-
ried into clinical practice without critical assessment. The utility of a 6-month
CT, with its associated radiation exposure and contrast toxicity, obtained after
a normal result at 1-month CT has not been established.
Methods. All EVAR patients from 1996 to 2004 at one institution with com-
plete local 1-year follow-up were reviewed for clinically significant CT find-
ings at 1, 6, and 12 months. Before 2000, all patients underwent 1-, 6-, and 12-
month CT. In 2000, a policy of omitting the 6-month CT in patients who had
a normal result on the 1-month scan was adopted.
Results. During the study period, 573 patients underwent EVAR, and 376 pa-
tients who had complete local 1-year follow-up were included in this review.
All had a 1-month CT scan and the result was abnormal in 40 (10.6%): five
had type 1 leaks (1.3%), 34 had type 2 leaks (9.0%), and one had a type 3
leak (0.3%); all were followed with 6-month CT. The 1-month CT scan result
was normal for 336 (89.4%) patients. Of these, group I (130 patients, 67 treated
after 2000) underwent routine 6-month CT, with only two abnormalities
noted (1.5%); both were type 2 endoleaks not associated with sac growth.
No 6-month CT in this group demonstrated findings warranting intervention.
The 6-month CTwas omitted in group II (206 patients, all treated after 2000),
and follow-up was only at 1 year. In this group, no patient’s management
would have been altered by findings on a 6-month CT. No patient in either
group experienced aneurysm sac growth by 1 year. Clinical complications oc-
curred in three group I patients (2.3%): seroma, limb occlusion, and main
body thrombosis. Only one group II patient (0.5%) experienced a complication
1 year, a limb occlusion at 9 months.
Conclusions. After EVAR, a 6-month CTafter a normal 1-month CTresult does
not identify any clinically significant findings warranting intervention and can
be omitted safely from the follow-up schedule.
Aortic remodeling after endografting of thoracoabdominal aortic
dissection
Julio A. Rodriguez, Dawn M. Olsen, Leonardo Lucas, Grayson Wheatley,
Venkatesh Ramaiah and Edward B. Diethrich
Purpose. This study assessed the clinical outcome, morphologic changes, and
behavior of acute and chronic type B aortic dissections after endovascular re-
pair and evaluated the extent of dissection and diameter changes in the true
(TL), false (FL), and whole lumen (WL) during follow-up.
Methods. From May 2000 to September 2006, preprocedural and follow-up
computed tomography scans were evaluated in 106 patients. Indices of the
TL (TLi) and FL (FLi) were calculated at the proximal (p), middle (m), and
distal (d) third of the descending thoracic aorta by dividing the TL or FL di-
ameter by the WL. Analyses were by paired t test and c2.
Results. Stent grafts were used to treat 106 patients (mean age, 55 years,
70% men) with acute 59 (55.7%) and chronic 47 (44.3%) lesions. The entry
site was successfully covered in 100 patients. The incidences of paraplegia
and paresis were 2.8% and 1.0%. Mortality was 7.5% (8 patients), including
two intraoperative deaths of contained ruptures. Seven (6.6%) early endo-
leaks occurred. At a mean follow-up of 15.6 months, TLi improved from
0.45 to 0.88 in the proximal third (p/3), from 0.42 to 0.81 in the middle third
(m/3), and from 0.44 to 0.74 in the distal third (d/3), demonstrating expan-
sion of the TL. Two patients had decrease in TL due to endoleak needing
reintervention. The FLi decreased from 0.41 to 0.06 in p/3, from 0.44 to
0.10 in the m/3, and from 0.42 to 0.21 in the d/3, indicating FL shrinkage.
Changes in the TLi and FLi were statistically significant. The decrease in the
WL after repair was statistically significant in the proximal and middle
aorta. Fourteen patients (13.2%) had increase in WL; seven required a second
intervention. FL thrombosis occurred in 69 (65.1%). During follow-up, 36
(36.9%) patients had no retrograde flow, with complete shrinkage of the
FL. The FL completely shrank in 28 patients (26.4%) despite retrograde
flow. The FL increased in eight patients (7.5%); five needed reintervention.
Thrombosis of FL was statistically significant with acute dissections and
when dissection remained above the diaphragm (type IIIA; P = .001 and
P = .0133).
Conclusion. Remodeling changes were seen when the entry tear was covered.
The fate of the FL was determined by persistent antegrade flow and the level
of the retrograde flow. Endografting for thoracic type B dissection was suc-
cessful and promoted positive aortic remodeling changes.
Stenting for carotid artery stenosis: Fractures, proposed etiology and
the need for surveillance
Adrian James Ling, Patrice Mwipatayi, Tarun Gandhi and Kishore Sieunarine
Purpose. Carotid artery stenting is a relatively new intervention for the treat-
ment of carotid artery stenosis, and the long-term outcomes and complica-
tions are therefore yet to be determined. In one surgeon’s practice, it was
found that a stent fracture was the etiological factor for recurrent stenosis. A
retrospective study was therefore performed with the hypothesis that carotid
stent fractures are common. The aims were to determine prevalence of frac-
tures in this surgeon’s series, risk factors, and most importantly, clinical
relevance.
Methods. Patients from one surgeon’s private practice who had carotid steno-
sis deemed suitable for intervention (>80% asymptomatic, >70% symptom-
atic, 50% to 70% if an ulcerated lesion) and had suitable aortic and carotid
morphology for carotid stenting between March 2004 and December 2006
were included. To enhance the quality of the measurement, two vascular sur-
geons and one radiologist examined the films independently to determine if
there was a fracture present. Given that this was a retrospective study, there
was no preconceived sample size determined.
Results. Fracture prevalence was found to be 29.2% or 14 out of 48 stents.
Restenosis occurred in 21% of those stents with a detected fracture, after an
average follow-up of 15 months. Several anetiological factors are proposed,
with a finding in this series, of a strong and significant association between
the presence of calcified vessels and the presence of fractures (odds ratio
7.7; standard error 5.6; 95% confidence interval 1.9-32.0, P =.003).
Conclusions. Although this is a small study, it demonstrates that carotid stent
fractures do exist, and importantly, not all of them are benign. Therefore, the
authors recommend regular surveillance with plain radiography in addition
to duplex ultrasonography to enable early detection of fracturing. Following
detection, institution of increased surveillance frequency and/or any appro-
priate intervention can be implemented, to aid in the prevention of complica-
tions resulting from restenosis should it become apparent.
Early remodeling of lower extremity vein grafts: Inflammation influences
biomechanical adaptation
Christopher D. Owens, Frank J. Rybicki, Nicole Wake, Andres Schanzer,
Dimitrios Mitsouras, Marie D. Gerhard-Herman and Michael S. Conte
Background. The remodeling of vein bypass grafts after arterialization is in-
completely understood. We have previously shown that significant outward
lumen remodeling occurs during the first month of implantation, but the
magnitude of this response is highly variable. We sought to examine the hy-
pothesis that systemic inflammation influences this early remodeling
response.
Methods. A prospective observational study was done of 75 patients under-
going lower extremity bypass using autogenous vein. Graft remodeling was
assessed using a combination of ultrasound imaging and two-dimensional
high-resolution magnetic resonance imaging.
Results. The vein graft lumen diameter change from 0 to 1 month (22.7% me-
dian increase) was positively correlated with initial shear stress (P = .016), but
this shear-dependent response was disrupted in subjects with an elevated
baseline high-sensitivity C-reactive protein (hsCRP) level of >5 mg/L.
Despite similar vein diameter and shear stress at implantation, grafts in the
elevated hsCRP group demonstrated less positive remodeling from 0 to
1 month (13.5% vs 40.9%, P = .0072). By regression analysis, the natural log-
arithm of hsCRP was inversely correlated with 0- to 1-month lumen diameter
change (P = .018). Statin therapy (b = 23.1, P = .037), hsCRP (b = 29.7,
P = .006), and initial shear stress (b = .85, P = .003) were independently corre-
lated with early vein graft remodeling. In contrast, wall thickness at 1 month
was not different between hsCRP risk groups. Grafts in the high hsCRP
group tended to be stiffer at 1 month, as reflected by a higher calculated elas-
tic modulus (E = 50.4 vs 25.1 Mdynes/cm2, P = .07).
Conclusions. Early positive remodeling of vein grafts is a shear-dependent
response that is modulated by systemic inflammation. These data suggest
that baseline inflammation influences vein graft healing, and therefore, in-
flammation may be a relevant therapeutic target to improve early vein graft
adaptation.
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Sclerotherapy after embolization of draining vein: A safe treatment
method for venous malformations
Yunbo Jin, Xiaoxi Lin, Wei Li, Xiaojie Hu, Gang Ma and Wei Wang
Background. Treatment of congenital venous malformations poses a major
clinical challenge. Great successes have been achieved with ethanol sclero-
therapy in most lesions; however, severe complications are more likely to
occur when more ethanol is used.
Objectives. This study evaluated the safety and efficacy of a new sclerother-
apy treatment that uses absolute alcohol and bleomycin A5. We evaluated our
experience to present a safe treatment method for venous malformations.
Methods. The study population comprised 201 patients. Before treatment, le-
sions were categorized according to magnetic resonance imaging features:
120 patients had limited venous malformations, and 81 had infiltrating ve-
nous malformations. Percutaneous sclerotherapy was performed by direct in-
jection of absolute alcohol and bleomycin A5 under fluoroscopy. The mean
dose of the two medicines was 3.4 mL and 3.7 mg, respectively. We investi-
gated 592 sclerotherapy sessions. A retrospective study was performed of
medical records and color photographs and magnetic resonance imaging
before and after treatment The mean follow-up was 29 months (range, 12-
65 months).
Results. After embolization of the drainage vein with ethanol, a subsequent
sclerosis therapy with bleomycin A5 was judged beneficial in 196 of 201 pa-
tients. Among the 196 responders, 56 showed disappearance of their chief
symptoms, 42 showed improvement to nearly normal, and 62 showed
marked improvement. The best response to our treatment was among the pa-
tients with limited venous malformations, with 114 (95%) showing at least
marked improvement. Complications were tissue necrosis in 6 sessions, pe-
ripheral nerve palsy in 5, pigmentation in 10, blistering in 5, and 87 sessions
resulted in transient side effects related to bleomycin A5, such as fever and
gastrointestinal irritation. All were self-limited. No major complications
such as cardiopulmonary collapse or pulmonary fibrosis were observed.
Conclusion. Percutaneous sclerotherapy of venous malformations using ab-
solute ethanol and bleomycin A5 is safe and effective. The simplicity, speed,
and safety of sclerotherapy, combined with the quality and stability of the
outcome achieved with our novel procedure, may make the technique the
choice for treatment of venous malformations.
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